New Vaccine Advances Could Help Against More Viral Illnesses

March 14, 2022 • by Marc Airhart

Some of the same researchers at The University of Texas at Austin who created a key to all coronavirus vaccines used in the U.S. have made a similar advance against the human metapneumovirus (hMPV), one of a handful of remaining respiratory viruses for which there is currently no vaccine.

Image of researchers Ching-Lin Hsieh and Jason McLellan at a computer screen reviewing data

Ching-Lin Hsieh and Jason McLellan are among the UT Austin scientists who have engineered a protein of the human metapneumovirus for use in vaccines. Credit: Vivian Abagiu


The structure of the human cytomegalovirus,

The structure of the human cytomegalovirus, a virus for which there is currently no vaccine. Credit: McLellan Lab

Share